- Exchange: Xetra
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
Snapshot for Bayer AG (BAYN)
| Open: | 86.460 | Day's Range: | 86.165 - 87.100 | Volume: | 932,280 |
|---|---|---|---|---|---|
| Previous Close: | 86.480 | 52wk Range: | 64.650 - 91.030 | 1-Yr Rtn: | +30.83% |
Key Statistics for BAYN
| Current P/E Ratio (ttm) | 24.6410 |
|---|---|
| Estimated P/E(12/2013) | 15.0522 |
| Relative P/E vs. DAX | 1.6661 |
| Earnings Per Share (EUR) (ttm) | 3.5100 |
| Est. EPS (EUR) (12/2013) | 5.7460 |
| Est. PEG Ratio | 1.3902 |
| Market Cap (M EUR) | 71,522.71 |
| Shares Outstanding (M) | 826.95 |
| 30 Day Average Volume | 1,916,577 |
| Price/Book (mrq) | 3.6809 |
| Price/Sale (ttm) | 1.7782 |
| Dividend Indicated Gross Yield | 2.20% |
| Cash Dividend (EUR) | 1.9000 |
| Dividend Ex-Date | 04/29/2013 |
| 5 Year Dividend Growth | 7.07% |
| Next Earnings Announcement | 10/31/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BAYN
Company Profile & Key Executives for BAYN
Bayer AG produces and markets healthcare and agricultural products, and polymers. The Company manufactures products that include aspirin, antibiotics, anti-infectives, and cardiovascular, oncology, and central nervous system drugs, over-the-counter medications, diagnostics, animal health products, crop protection products, plastics, and polyurethanes.
| Marijn E DekkersChairman-Mgmt Board/CEO | Werner BaumannCFO/Member-Mgmt Board |
| Wolfgang PlischkeCTO/Member-Mgmt Board | Michael KoenigChief Human Resources Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
Advertisement
-
BAYN News
-
Industry News
Advertisement
Sponsored Links
Advertisements
Rate this Page